Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4864612 | 1.00 | APLNR (0.42) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL3384406 | 1.00 | APLNR (0.42) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL6809952 | 1.00 | APLNR (0.42) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL1067196 | 0.97 | — | — | |
| SCHEMBL12385979 | 0.97 | — | — | |
| SCHEMBL4919619 | 0.97 | — | — | |
| SCHEMBL9683163 | 0.94 | APLNR (0.42) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| Lithium SCHEMBL8041363 | 0.94 | — | — | |
| SCHEMBL21057278 | 0.85 | APLNR (0.41) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL21057276 | 0.85 | APLNR (0.41) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2903979-B1 | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES | INHIBIKASE THERAPEUTICS INC (US) | 2020-08-19 | — | — | EP | claimed |
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11414615-B2 | Power transmission lubricant oil base oil | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2022-08-16 | — | — | US | disclosed |
| US-11377425-B1 | Small molecule modulators of IL-17 | LEO PHARMA A/S (DK) | 2022-07-05 | — | — | US | disclosed |
| US-20210340456-A1 | POWER TRANSMISSION LUBRICANT OIL BASE OIL | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-11-04 | — | — | US | disclosed |
| CN-1200382-A | Propylene polymer blends, processes of producing same, and polypropylene resin compositions | CHISSO CORP (JP) | 1998-12-02 | — | — | CN | disclosed |
| EP-0863183-A1 | PROPYLENE COMPOSITION, PROCESS FOR PREPARING THE SAME, POLYPROPYLENE COMPOSITION, AND MOLDED ARTICLES | CHISSO CORPORATION (JP) | 1998-09-09 | — | — | EP | disclosed |
| EP-0622404-B1 | Crystalline synthetic resin composition containing a group III or IV metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KK (JP) | 1998-07-08 | — | — | EP | disclosed |
| CN-1168905-A | Thermoplastic resin composition, sheet thereof and wrapping vessel thereof | TONEN SEKIYUKAGAKU KK (JP) | 1997-12-31 | — | — | CN | disclosed |
| EP-0790262-A1 | PROPYLENE-ETHYLENE COPOLYMER COMPOSITIONS AND PROCESS FOR THE PRODUCTION THEREOF | CHISSO CORPORATION (JP) | 1997-08-20 | — | — | EP | disclosed |
| US-5646144-A | FOR TREATING DISORDERS IN WHICH SUBSTANCE P PLAYS A PART IN DEVELOPMENT | CIBA-GEIGY CORPORATION (US) | 1997-07-08 | — | — | US | disclosed |
| US-5541195-A | SUBSTANCE P ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0622404-A1 | Crystalline synthetic resin composition containing a group III or IV metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5342868-A | Containing alkali metal salt and polyvalent metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1994-08-30 | — | — | US | disclosed |
| US-5310743-A | Substance P antagonist | CIBA-GEIGY CORP. (US) | 1994-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377425-B1 | Small molecule modulators of IL-17 | IL17A, IL15, IL2 | APLNR 3303/4885CYP2C19 422/4885GABRR1 4151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.